Temasek Holdings Invests in Round in Portola Pharmaceuticals

Posted on 11/22/2011


Singapore’s Temasek Holdings along with other investors invested a round of US$ 89 million in Portola Pharmaceuticals via preferred equity. Portola Pharmaceuticals is a San Francisco biotech company that is working on an anti-clotting drug called betrixaban. This financing is for pushing the development through its Phase III betrixaban trial. Eight months ago Merck dropped […]